Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875520 · ClinicalTrials.gov registry record · NA
Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 1,390
- Enrollment target
NCT04875520: Completed NA study, sponsored by Washington University School of Medicine.
NCT04875520 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 1,390 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04875520, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,390 participants
- Enrollment target
Study Summary
The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis. Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in areas of high community transmission. We will compare the effectiveness and acceptance of two different school-based testing strategies among students and school staff (symptomatic testing only versus weekly surveillance testing plus symptomatic testing), measuring school-based SARS-CoV-2 transmission through a cluster randomized trial.
Primary Outcome
The rate of all new COVID-19 cases of student/staff in schools per randomization group.
Interventions
- OTHER Screening testing strategy
- OTHER No screening testing strategy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,390 participants |
| Start Date | 2021-05-07 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04875520 record still lists
NCT04875520 is an interventional study that assigns participants to a tested intervention. Its 1,390 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Screening testing strategy is the first listed.
NCT04875520 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04875520 about?
NCT04875520 is a clinical study titled "Assessing Testing Strategies for Safe Return to K-12 Schools in an Underserved Population". The primary goal of this study is to determine the most effective SARS-CoV-2 testing strategy for successful return of in-person school in the under-served communities of St. Louis. Regular screening testing has been recommended by the CDC as an additive mitigation strategy for in-person schools in...
What is the current status of trial NCT04875520?
This trial is currently completed. It is a NA study. The enrollment target is 1,390 participants. The study started on 2021-05-07. Estimated completion is 2023-12-31.
What interventions are being tested in trial NCT04875520?
The interventions under investigation include: Screening testing strategy (OTHER), No screening testing strategy (OTHER).
Who is sponsoring clinical trial NCT04875520?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04875520's enrollment target sits among peer trials
1,390 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05006131 · 1,395 participants
Pancreatic Cancer Screening for At-risk Individuals
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
- NCT03145077 · 1,400 participants · NA
Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI